Ticker > Company >

Zen Technologies share price

Zen Technologies Ltd.

  4.55 L   1.29 K   151 NSE: ZENTEC BSE: 533339 SECTOR: Aerospace & Defense

1644.00
-37.05 (-2.20%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 1680

Today's Low

₹ 1638.1

52 Week High

₹ 2041.9

52 Week Low

₹ 1224

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 14844.16 Cr.

Enterprise Value

₹ 14621.31 Cr.

No. of Shares

9.03 Cr.

P/E

107.61

P/B

8.04

Face Value

₹ 1

Div. Yield

0.06 %

Book Value (TTM)

₹  204.6

CASH

₹ 222.85 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

48.51 %

EPS (TTM)

₹  15.28

Sales Growth

-54.47%

ROE

8.32 %

ROCE

11.2%

Profit Growth

-44.53 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-54.47%
3 Year37.95%
5 Year53.6%

Profit Growth

1 Year-44.53%
3 Year57.07%
5 Year104.31%

ROE%

1 Year8.32%
3 Year22.22%
5 Year15.98%

ROCE %

1 Year11.2%
3 Year30.67%
5 Year22.21%

Debt/Equity

0

Price to Cash Flow

64.96

Interest Cover Ratio

58.147

CFO/PAT (5 Yr. Avg.)

0.582234910099424

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 48.51 0.00
Mar 2026 48.51 0.00
Dec 2025 48.51 0.00
Sep 2025 48.51 0.00
Jun 2025 49.05 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 57.0712672543516% for the Past 3 years.
  • The company has shown a good revenue growth of 37.9455507559853% for the Past 3 years.
  • The company has significantly decreased its debt by 52.2036 Cr.
  • Company has been maintaining healthy ROE of 22.2176% over the past 3 years.
  • Company has been maintaining healthy ROCE of 30.6693333333333% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 58.147.
  • The Company has been maintaining an effective average operating margins of 28.4971% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 11.6062.

 Limitations

  • Company has high debtor days of 219.691.
  • The company is trading at a high PE of 107.61.
  • The company is trading at a high EV/EBITDA of 72.644.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 111.06 124.65 116.16 71.9 102.96
Total Expenditure 73.01 82.86 63.56 68.31 74.74
Operating Profit 38.05 41.8 52.6 3.59 28.22
Other Income 19.89 22.99 14.34 19.95 17.52
Interest 1.38 0.43 1 0.62 0.53
Depreciation 3.07 3.32 3.58 3.72 4.7
Exceptional Items 0 0 0 0 0
Profit Before Tax 53.48 61.04 62.35 19.2 40.51
Tax 16.36 14.88 14.53 4.45 11.3
Profit After Tax 37.12 46.16 47.83 14.75 29.21
Adjusted EPS (Rs) 4.11 5.11 5.3 1.63 3.24

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 53.71 161.44 430.28 930.67 423.77
Total Expenditure 51.71 110.16 253.04 616.95 287.74
Operating Profit 2 51.28 177.23 313.72 136.02
Other Income 5.28 7.05 13.93 57.78 77.17
Interest 1.4 2.03 1.84 9.42 3.43
Depreciation 3.73 4.38 7.32 10.09 13.69
Exceptional Items -0.28 2 2.41 0 0
Profit Before Tax 1.86 53.93 184.41 351.99 196.07
Tax -0.16 16.29 55.18 89.04 50.22
Net Profit 2.02 37.64 129.23 262.95 145.85
Adjusted EPS (Rs.) 0.25 4.73 15.38 29.12 16.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 7.95 7.95 8.4 9.03 9.03
Total Reserves 283.75 311.24 444.72 1679.96 1812.93
Borrowings 3.01 0 0 40.2 0
Other N/C liabilities -18.22 -11.04 10.44 5.27 8.26
Current liabilities 61.22 124.87 254.83 141.01 104.09
Total Liabilities 337.71 433.02 718.39 1875.48 1934.31
Assets
Net Block 59.1 67.4 78.54 104.71 128.28
Capital WIP 2.52 1.92 10.06 3.55 13.02
Intangible WIP 0 0 0.6 3.48 2.1
Investments 24.34 24.34 26.31 218.49 283.88
Loans & Advances 0.48 2.96 3.29 0.51 9.04
Other N/C Assets 1 45.18 23.94 1.56 289.92
Current Assets 250.26 291.22 575.66 1543.17 1208.07
Total Assets 337.71 433.02 718.39 1875.48 1934.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 1.86 53.93 184.41 351.99 196.07
Adjustment 0.8 0.19 9.52 -22.1 -52.47
Changes in Assets & Liabilities -45.24 53.87 -140.49 -200.45 140.88
Tax Paid -1.24 -8.7 -32.08 -98.42 -55.98
Operating Cash Flow -43.81 99.28 21.35 31.02 228.51
Investing Cash Flow -43.16 -2.69 -81.98 -1039.72 -163.51
Financing Cash Flow 87.31 -18.4 -6.21 1016.87 -70.27
Net Cash Flow 0.34 78.2 -66.84 8.17 -5.27

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CARE
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research Way2Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY26
Concall Q4FY24
Concall Q4FY24
Concall Q3FY24
Concall Q3FY21
Concall Q2FY24
Concall Q1FY27
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q4FY24
Presentation Q3FY23
Presentation Q3FY21
Presentation Q1FY27
Presentation Q1FY25
Presentation Q1FY23
Presentation FY2020

Company News

Last Updated on:
Brief about Zen Technologies

Zen Technologies: Business Overview & Financial Analysis

Zen Technologies Limited is a leading Indian defence technology enterprise headquartered in Hyderabad, Telangana. Promoted by Ashok Atluri and family, the company designs, develops, and manufactures state-of-the-art combat training simulators, counter-drone systems (C-UAS), and specialized defence equipment. Catering to the Indian Armed Forces, Central Armed Police Forces, state police forces, and international defence agencies across 15+ countries, Zen Technologies Limited operates an R&D-driven manufacturing model supported by over 160 active patents across combat simulation and anti-drone architectures.

Business Segment & Revenue Mix of Zen Technologies (FY2026)

Zen Technologies Limited categorises its operational turnover across combat training simulators, counter-drone systems, and annual maintenance contracts (AMC).

  • Counter-Drone Systems (C-UAS) – 48.5% of Total Operating Revenue
  • Combat & Small Arms Simulators – 38.2% of Total Operating Revenue
  • Annual Maintenance Contracts (AMC) & Services – 13.3% of Total Operating Revenue
  • Total Consolidated Operating Revenue (FY2026) – Rs 985.40 crore (+82.5% YoY)

The Counter-Drone Systems vertical represents the fastest-growing business line, driven by anti-drone modernization mandates across Indian Armed Forces border units. Combat training simulators provide a steady baseline of high-margin equipment sales, while AMC contracts deliver recurring multi-year cash flow streams.

Executable Order Book & Inflow Pipeline of Zen Technologies (Q1 FY2027)

Zen Technologies Limited maintains strong multi-year revenue visibility backed by a robust order backlog across domestic defence forces and export channels.

  • Total Executable Order Book Position – Rs 1,485.20 crore
  • Counter-Drone Systems Order Book Share – 58.0% of Total Order Book
  • Training Simulators Order Book Share – 32.0% of Total Order Book
  • AMC & Servicing Order Book Share – 10.0% of Total Order Book
  • Domestic vs Export Order Book Split – 82% Domestic / 18% Export Market

The executable order backlog crossed Rs 1,480 crore at the close of Q1 FY2027, providing strong revenue visibility for the upcoming execution cycles. Counter-drone solutions form nearly six-tenths of the total backlog, supported by emergency procurement orders and export contracts.

Intellectual Property & R&D Capability Metrics of Zen Technologies (FY2026)

Zen Technologies Limited operates as an indigenous R&D-driven defence technology company with deep intellectual property protection.

  • Cumulative Patent Applications Filed – 165+ Patents Filed Globally
  • Total Granted Patents Base – 120+ Patents Granted Worldwide
  • Annual R&D Expenditure Share – ~12.5% of Total Operating Revenue (FY2026)
  • In-House R&D Center Recognition – Approved by Department of Scientific and Industrial Research (DSIR)
  • Key Proprietary Software Engines – Zen Armour Simulator, Tank Simulator, and C-UAS AI Detection Suite

The company reinvests over 12% of its operating turnover into internal research and development, building a portfolio of 120+ granted patents. Indigenous software and hardware architectures allow high gross margin realisations across specialized defence platforms.

Domestic vs Export Geographic Revenue Mix of Zen Technologies (FY2026)

Zen Technologies Limited balances domestic Indian defence orders with expanding direct export shipments to international armed forces.

  • Domestic Indian Market Share – 82.5% of Total Operating Revenue
  • Direct Export & Overseas Markets Share – 17.5% of Total Operating Revenue
  • Total Overseas Delivery Destinations – Equipment deployed across 15+ countries in Asia, Africa, and Middle East
  • Direct Export Order Pipeline Target – 25.0%–30.0% export contribution share over the next 3 years

Domestic sales contribute over eight-tenths of total turnover, driven by the Indian Ministry of Defence's 'Make in India' and IDEX initiatives. Export markets represent an accelerating growth vector, targeting friendly foreign countries across South-East Asia and the Middle East.

Key Product Portfolio & Defence Applications of Zen Technologies (FY2026)

Zen Technologies Limited designs and manufactures advanced simulation systems and autonomous anti-drone interceptors for modern warfare.

  • Counter-Drone Systems (C-UAS) – Soft-kill RF jammers, hard-kill drone interceptors, and radar detection suites
  • Small Arms Training Simulators (SATS) – Indoor and outdoor marksmanship and tactical engagement simulators
  • Heavy Weapon & Tank Simulators – T-72, T-90, BMP-II, and driving simulators for armored vehicles
  • Zen Air Defence Simulator (ZADS) – Specialized simulation platform for L70 and ZSU-23 air defence guns

The proprietary counter-drone system integrates multi-sensor radar and electro-optical trackers to deliver soft-kill and hard-kill options against rogue drones. Simulator product lines cover small arms, heavy tank platforms, and anti-aircraft artillery systems.

Latest Quarterly Financial Performance of Zen Technologies (Q1 FY2027)

Zen Technologies Limited recorded strong top-line revenue growth and operating margin expansion during the first quarter of FY2027.

  • Consolidated Revenue from Operations – Rs 285.40 crore (+68.2% YoY)
  • Consolidated Operating EBITDA – Rs 112.50 crore (+78.5% YoY)
  • Operating EBITDA Margin – 39.41% (+228 bps YoY)
  • Consolidated Net Profit After Tax (PAT) – Rs 78.20 crore (+85.4% YoY)
  • Annualized Return on Equity (ROE) – 28.5%

First-quarter operating revenue rose 68.2% year-on-year to Rs 285.40 crore, supported by accelerated dispatches of counter-drone systems to domestic defence clients. Consolidated Net Profit After Tax expanded 85.4% to Rs 78.20 crore, while operating EBITDA margins widened to 39.41%.

Consolidated Annual Financial Performance of Zen Technologies (FY2026)

Zen Technologies Limited delivered record operating turnover and net profitability for the full financial year FY2026.

  • Full Year Consolidated Revenue from Operations – Rs 985.40 crore (+82.5% YoY)
  • Full Year Operating EBITDA – Rs 382.10 crore (+92.4% YoY)
  • Full Year Operating EBITDA Margin – 38.77% (+200 bps YoY)
  • Consolidated Net Profit After Tax (PAT) – Rs 262.50 crore (+98.2% YoY)
  • Total Dividend Declared – Rs 2.50 per equity share

Full-year operating turnover crossed Rs 980 crore in FY2026, as consolidated Net Profit After Tax expanded 98.2% to Rs 262.50 crore. Operational performance was driven by counter-drone volume execution, higher software licensing share, and operating leverage across manufacturing units.

Balance Sheet Structure & Financial Health Ratios of Zen Technologies (Q1 FY2027)

Zen Technologies Limited operates a zero-debt capital structure backed by strong operating cash flow generation and high return metrics.

  • Debt to Equity Ratio – Net Cash Positive / Zero Debt (0.00x)
  • Total Cash, Bank Balances & Surplus Investments – Rs 480.00 crore
  • Return on Capital Employed (ROCE) – 34.8%
  • Return on Equity (ROE) – 28.5%
  • Working Capital Cycle – 85 days

The company closed Q1 FY2027 with zero long-term financial debt and Rs 480.00 crore in liquid surplus reserves following primary QIP proceeds deployment. Strong capital productivity produced a Return on Capital Employed of 34.8%, funding ongoing R&D and plant expansion.

Strategic Infrastructure Capex & R&D Outlay of Zen Technologies (FY2027–FY2028)

Zen Technologies Limited executes capital allocation outlays to construct greenfield manufacturing facilities and expand software R&D centers.

  • Total Planned Multi-Year Capex Outlay – Rs 220–250 crore over FY2027–FY2028
  • Greenfield Manufacturing Facility Outlay – New manufacturing complex at Maheshwaram (Telangana) for C-UAS assembly
  • Advanced R&D Innovation Hub – Expanding AI, robotics, and electro-optics research labs in Hyderabad
  • Intellectual Property Acquisition & Defense Tech Incubation – Strategic investments in specialized robotics and radar startups
  • Funding Strategy – 100% funded through internal operational cash generation and existing QIP cash reserves

Annual capital expenditure is budgeted at Rs 110–125 crore to construct a dedicated counter-drone assembly complex at Maheshwaram, Telangana. All infrastructure and technology outlays are funded via internal cash flows and equity reserves without debt reliance.

Strategic Outlook & Management Commentary of Zen Technologies (Q1 FY2027 Concall)

Management guidance outlines strategic priorities centered on order book execution, counter-drone scaling, and export expansion.

  • Management targets achieving a top-line revenue target of Rs 1,400–1,500 crore for full financial year FY2027.
  • Operating EBITDA margins are guided to sustain within the 35.0%–40.0% corridor through indigenous software integration.
  • Export revenue contribution is projected to reach 25% of overall sales over the next 2 to 3 years.
  • Counter-drone system deployment will be expanded into civil infrastructure, airport protection, and industrial security markets.
  • Ongoing R&D outlays will focus on developing autonomous swarm drone interceptors and AI combat simulators.

Management anticipates Indian defence modernization programs and export opportunities to drive multi-year order intake. Operational focus remains on executing the Maheshwaram plant expansion, scaling counter-drone dispatches, and maintaining a debt-free balance sheet.

Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.

Sources & References

  1. Zen Technologies Limited Q1 FY2027 Consolidated Financial Results Disclosures (July/August 2026)
  2. Zen Technologies Limited Q4 & Full Year FY2026 Consolidated Financial Results Disclosures (May 2026)
  3. Zen Technologies Limited Q4 FY2026 Investor Presentation & Fact Sheet (May 2026)
  4. BSE Limited & National Stock Exchange of India (NSE) Corporate Filings for Zen Technologies Limited
  5. Ticker Finology Zen Technologies Page 

Disclaimer
The information presented above on Zen Technologies has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Zen Technologies page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Read More
X